shutterstock-98186870-web
michaeljung / Shutterstock.com
18 July 2014Europe

MPP signs licences to increase access to HIV drugs

The Medicines Patent Pool (MPP) has announced seven new sub-licensing agreements to make generic HIV medicines atazanavir (ATV) and dolutegravir (DTG).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk